REMEDY : BNSSG referral pathways & Joint Formulary


Home > BNSSG ICB > Development Area >

Hospital Discharge Pathways (DRAFT)

Checked: not set yet by Vicky Ryan Next Review: not set yet

Overview

In BNSSG there are 4 hospital discharge pathways. These are know as Discharge to Assess (D2A).

In summary the pathways are:

Pathway 0: Home without formal support needs.
Most people will go home on this pathway.
Person discharged to the place they call home with no new NHS or social care support, but may receive informal support from friends, family or VCSE.


Pathway 1: Recovery and rehab at home.
The vast majority of people who need formal support at discharge will go home on this pathway.
Person supported to rehabilitate at home with tailored package of therapy and any other support needed.


Pathway 2: Rehab to home.
Only a few people will leave hospital on this pathway.
Person needs high level of support or rehabilitation that cannot be provided at home and continues recovery in community rehabilitation unit before returning home.


Pathway 3: Community bed.
Very few people will leave hospital on this pathway.
Person needs 24-hour bed-based care which is likely to be ongoing. They are cared for in a community assessment bed while long term needs are assessed and arranged.

 

Full details are given on the D2A pathways Staff Summary

Queries

If GPs have concerns about an individuals care pathway, the first point of contact would be the Sirona SPA Tel: 0300 125 6789

Please also see the Urgent Community Response - Sirona Remedy page.



Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.